94
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Prediction of CD34 + cell yield in hematopoietic cell products from children by peripheral blood CD34 + cell counts

, , , , , , & show all
Pages 473-482 | Published online: 15 Mar 2012

References

  • Reiffers J, Marit G, Vezon G, Cony-Makhoul P, Boiron JM, Montastruc M, . Autologous blood stem cell grafting in hematological malignancies. Present status and future directions. Transfus Sci. 1992;13:399–405.
  • Simnett SJ, Stewart LA, Sweetenham J, Morgan G, Johnson PW. Autologous stem cell transplantation for malignancy: a systematic review of the literature. Clin Lab Haematol. 2000;22:61–72.
  • Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood. 1991;77:211–3.
  • To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, . Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant. 1992;9:277–84.
  • Schwartzberg L, Birch R, Blanco R, Wittlin F, Muscato J, Tauer K, . Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant. 1993; 11:369–74.
  • Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, . Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet. 1992;339:640–4.
  • Smith TJ, Hillner BE, Schmitz N, Linch DC, Dreger P, Goldstone AH, . Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. J Clin Oncol. 1997;15:5–10.
  • To LB, Dyson PG, Branford AL, Russell JA, Haylock DN, Ho JQ, . Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous haemopoietic reconstitution in acute non-lymphoblastic leukaemia. Bone Marrow Transplant. 1987;2:103–8.
  • Uyl-de Groot CA, Richel DJ, Rutten FF. Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation. Eur J Cancer. 1994;30A:1631–5.
  • Malachowski ME, Comenzo RL, Hillyer CD, Tiegerman KO, Berkman EM. Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion. 1992;32:732–5.
  • Comenzo RL, Vosburgh E, Weintraub LR, Tansan S, Arkin CF, Wright DG. Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis. Transfusion. 1995;35:493–7.
  • Murea S, Goldschmidt H, Hahn U, Pforsich M, Moos M, Haas R. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses. J Clin Apher. 1996;11:185–94.
  • Gertz MA. Current status of stem cell mobilization. Br J Haematol. 2010;150:647–62.
  • D'Arena G, Musto P, Di Mauro L, Cascavilla N, Iacono ND, Scalzulli PR, . Predictive parameters for mobilized peripheral blood CD34 + progenitor cell collection in patients with hematological malignancies. Am J Hematol. 1998;58:255–62.
  • Schwella N, Beyer J, Schwaner I, Heuft HG, Rick O, Huhn D, . Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol. 1996;14:1114–21.
  • Schwella N, Siegert W, Beyer J, Rick O, Zingsem J, Eckstein R, . Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution. Ann Hematol. 1995;71:227–34.
  • Benjamin RJ, Linsley L, Fountain D, Churchill WH, Sieff C, Cannon ME, . Preapheresis peripheral blood CD34 + mononuclear cell counts as predictors of progenitor cell yield. Transfusion. 1997;37:79–85.
  • Diaz MA, Garcia-Sanchez F, Lillo R, Vicent MG, Vicario JL, Madero L. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34 + cell count predicts progenitor cell yield. Haematologica. 1999;84:32–5.
  • Alegre A, Diaz MA, Madero L, Granda A, de la Vega A, Villa M, . Large-volume leukapheresis for peripheral blood stem cell collection in children: a simplified single-apheresis approach. Bone Marrow Transplant. 1996;17:923–7.
  • Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant. 1997;20:587–91.
  • Fruehauf S, Schmitt K, Veldwijk MR, Topaly J, Benner A, Zeller WJ, . Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patients. Br J Haematol. 1999;105:786–94.
  • Lipschitz DA, Udupa KB, Milton KY, Thompson CO. Effect of age on hematopoiesis in man. Blood. 1984;63:502–9.
  • Waterstrat A, Van Zant G. Effects of aging on hematopoietic stem and progenitor cells. Curr Opin Immunol. 2009;21: 408–13.
  • Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, . Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol. 1994;87:825–31.
  • Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, . Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 1994;83: 3787–94.
  • Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother. 1992;1:329–41.
  • Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34 + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26.
  • Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8:283–98.
  • Fontao-Wendel R, Lazar A, Melges S, Altobeli C, Wendel S. The absolute number of circulating CD34 + cells as the best predictor of peripheral hematopoietic stem cell yield. J Hematother. 1999;8:255–62.
  • Elliott C, Samson DM, Armitage S, Lyttelton MP, McGuigan D, Hargreaves R, . When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol. 1996;14:970–3.
  • Luider J, Brown C, Selinger S, Quinlan D, Karlsson L, Ruether D, . Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis. J Hematother. 1997;6:575–80.
  • Russell JA, Luider J, Weaver M, Brown C, Selinger S, Railton C, . Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant. 1995;15:111–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.